Some suspected cancer pathways have been CHANGED in response to Covid-19. Revised guidance and updated 2WW referral forms have been implemented for certain cancers. For the latest Covid-19 related news on cancer referrals and treatment see the Cancer section on the NCL Covid-19 GP intranet. The information is not repeated on this website.
NCL has implemented a 2WW teledermatology pathway (Royal Free and Whittington only):
Healthy London Partnership Covid-19 Cancer Referral Resources
This page hosts Covid-19 related support documents for primary care during the Covid-19 outbreak. It includes Covid-19 specific pan-London suspected cancer referral forms (also available on Islington EMIS), a Covid-19 patient information leaflet as well as primary care educational guides and communications.
Please remember GPs can refer direct to hospitals for urgent diagnostics and consider this instead of 2WW. For a full breakdown of where and how to refer, read this guide.
The Multidisciplinary Diagnostic Centre (GI cancer) is going well. Please continue to refer.
See the latest NCL GP and Primary Care Cancer Newsletter (January 2020)
GP one-to-one practice support: cancer research faciliator
Cancer Research UK is able to visit practices individually as and when needed to share the latest local cancer data, provide training and tools on key topics such as cancer screening. Islington’s facilitator Christine Harding is able discuss new NICE guidance with valuable resources, support the completion of SEAs and audits. GPs will be able to review surgery safety netting processes and best practice.
Please contact Christine for further information and/or to set up a visit:
View the Cancer Education page for learning resources and referral guides.